These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


247 related items for PubMed ID: 17598435

  • 1. [Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report].
    Milejski P, Orzechowska-Juzwenko K, Niewiński P, Hurkacz M, Czarnik-Matusewicz H, Leszek J, Rudzik J, Grotthus B.
    Psychiatr Pol; 2007; 41(2):261-9. PubMed ID: 17598435
    [Abstract] [Full Text] [Related]

  • 2. [Clinical significance of oxidation and acetylation genetic polymorphism in patients with Parkinson's disease].
    Milejski P, Orzechowska-Juzwenko K, Kamienowski J, Horoch E, Niewiński P, Hurkacz M, Rzemisławska Z.
    Neurol Neurochir Pol; 1999; 33(5):1015-24. PubMed ID: 10672554
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical significance of oxidation and acetylation genetic polymorphism in patients with hyperthyreosis].
    Milejski P, Orzechowska-Juzwenko K, Niewiński P, Hurkacz M, Czarnik-Matusewicz H, Forkasiewicz Z, Dawiskiba J, Bednarz W, Domosławski P.
    Endokrynol Pol; 2006; 57(6):605-11. PubMed ID: 17253433
    [Abstract] [Full Text] [Related]

  • 5. Acetylator polymorphism in Alzheimer's disease.
    Ladero JM, Barquero MS, Coria F, Molina JA, Jiménez-Jiménez FJ, Benítez J.
    Eur J Med; 1993 May; 2(5):281-3. PubMed ID: 8252158
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acetylator phenotype in patients with allergic diseases and its clinical significance.
    Orzechowska-Juzwenko K, Milejski P, Patkowski J, Nittner-Marszalska M, Malolepszy J.
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):420-5. PubMed ID: 2258251
    [Abstract] [Full Text] [Related]

  • 9. [Oxidation phenotype as a risk factor for development of allergic diseases].
    Niewiński P, Orzechowska-Juzwenko K, Patkowski J, Wolańczyk-Medrala A, Nittner-Marszalska M, Rzemisławska Z.
    Pol Arch Med Wewn; 1999 Jan; 101(1):23-7. PubMed ID: 10592724
    [Abstract] [Full Text] [Related]

  • 10. [Sparteine oxidation by hepatic cytochrome P-450 in patients with Parkinson's disease].
    Yoshino H, Hattori Y, Imai H, Narabayashi H, Chiba K.
    Rinsho Shinkeigaku; 1993 Mar; 33(3):261-5. PubMed ID: 8334787
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oxidative phenotype polymorphism (P450 2D6) and metabolism of toluene.
    Pelclová D, Mráz J, Patzelová V, Pícková J, Pospísil J, Vodicková L, Hornychová M, Vejlupková J.
    Int J Clin Pharmacol Ther; 1996 Jan; 34(1):38-42. PubMed ID: 8688995
    [Abstract] [Full Text] [Related]

  • 13. N-acetylation phenotyping with sulfamethazine in an Iranian population.
    Sardaş S, Lahijany B, Cok I, Karakaya AE.
    Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
    [Abstract] [Full Text] [Related]

  • 14. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
    Ylitalo P, Auterinen L, Marttinen A, Koivula T.
    Int J Clin Pharmacol Res; 1984 Jun; 4(2):141-4. PubMed ID: 6469440
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
    Peters JH, Gordon GR, Lin E, Green CE, Tyson CA.
    Anticancer Res; 1990 Jun; 10(1):225-9. PubMed ID: 2334132
    [Abstract] [Full Text] [Related]

  • 18. Oxidative phenotype status in related subjects.
    Rychlik-Sych M, Łyczba M, Skretkowicz J.
    Acta Pol Pharm; 2008 Jun; 65(1):165-8. PubMed ID: 18536192
    [Abstract] [Full Text] [Related]

  • 19. [Acetylation phenotype in Graves' disease].
    Górnik W, Syrenicz A, Gawrońska-Szklarz B, Wójcicki J.
    Pol Tyg Lek; 2008 Jun; 44(32-33):743-5. PubMed ID: 2641798
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.